MINK THERAPEUTICS
MiNK Therapeutics is a clinical stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. MiNK is advancing a pipeline of both native and next-generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
MINK THERAPEUTICS
Industry:
Biopharma Biotechnology Manufacturing
Founded:
2017-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.minktherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
212.994.8250
Email Addresses:
[email protected]
Technology used in webpage:
SPF Euro Google Google Cloud Google Cloud Iowa Zoom Video Conferencing Zoom DNS Made Easy DNS Dropbox Business
Current Employees Featured
Stock Details
Official Site Inspections
http://www.minktherapeutics.com Semrush global rank: 2.29 M Semrush visits lastest month: 8.25 K
- Host name: 197.48.209.35.bc.googleusercontent.com
- IP address: 35.209.48.197
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "MiNK Therapeutics"
MiNK Therapeutics - LinkedIn
MiNK Therapeutics | 5,442 followers on LinkedIn. Changing lives through living medicines. | We are a clinical stage biopharmaceutical company pioneering the discovery, development, and ...See details»
Investor Relations - MiNK Therapeutics
NEW YORK , March 04, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics , Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, …See details»
MiNK Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number 212.994.8250 MiNK Therapeutics is a clinical stage biopharmaceutical company pioneering …See details»
Contact - MiNK Therapeutics
315 Cambridge Science Park Milton Road Cambridge. CB4 OWG United KingdomSee details»
MiNK Therapeutics to Provide Corporate Update and Fourth …
NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and …See details»
MiNK Therapeutics, Inc. - AnnualReports.com
MiNK Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery, development and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated …See details»
Careers - MiNK Therapeutics
At MiNK Therapeutics, we’re passionate about developing novel cell therapies using our iNKT technology platform to improve the lives of patients worldwide. We have created a collaborative and inclusive environment that thrives on …See details»
MiNK Therapeutics Inc. - Cruelty Free Investing
MiNK Therapeutics, Inc. is a biopharmaceutical company. The Company is specialized in discovery, development and commercialization of allogeneic, off-the-shelf, invariant natural …See details»
MiNK Therapeutics Company Profile - Office Locations ... - Craft
Oct 29, 2024 MiNK Therapeutics has 1 employees across 2 locations. See insights on MiNK Therapeutics including office locations, competitors, revenue, financials, executives, …See details»
MiNK Therapeutics Company Profile | Management and …
Www.minktherapeutics.com MiNK Therapeutics Profile and History MiNK Therapeutics is a biopharmaceutical company pioneering the discovery, development, and commercialization of …See details»
MiNK Therapeutics Regains Full Compliance with Nasdaq
NEW YORK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery,...See details»
MiNK Therapeutics - Overview, News & Similar companies
Jun 5, 2023 MiNK Therapeutics contact info: Phone number: (212) 994-8250 Website: www.minktherapeutics.com What does MiNK Therapeutics do? MiNK Therapeutics is a …See details»
MiNK Therapeutics to Provide Corporate Update and First Quarter …
1 day ago NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, …See details»
MiNK Therapeutics to Provide Corporate Update and First
1 day ago For more information, visit https://minktherapeutics.com or @MiNK_iNKT. Information that may be important to investors will be routinely posted on our website and social media …See details»
ImmunoScape and MiNK Therapeutics Collaborate to Accelerate …
Dec 20, 2023 MiNK Therapeutics combines its unique, proprietary library of T-cell antigens with ImmunoScape’s cutting-edge platform for rapid discovery of novel T-cell receptors ; …See details»
MiNK Therapeutics to Provide Corporate Update and First Quarter …
1 day ago NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, …See details»
MiNK Therapeutics, Inc. - Drug pipelines, Patents, Clinical
Investor [email protected] Media [email protected] . Cell Therapy Phase 2 ASCO Immunotherapy. …See details»
MiNK Therapeutics to Provide Corporate Update and Fourth
Mar 4, 2025 For more information, visit https://minktherapeutics.com or @MiNK_iNKT. Information that may be important to investors will be routinely posted on our website and …See details»
MiNK Therapeutics to Announce Q1 2025 Financial Results and
1 day ago MiNK Therapeutics will announce Q1 2025 financial results on May 15, followed by a conference call at 8:30 a.m. ET. MiNK Therapeutics, Inc. announced that it will release its first …See details»
MiNK Therapeutics to Provide Corporate Update and Third
NEW YORK, Nov. 11, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery,...See details»